In this review, we will highlight the emerging knowledge and our recent findings showing the role of PDE5 as a tumor biomarker as well as a potential target for therapeutic strategies aimed at controlling and eventually curing malignant diseases. This evidence concerns the gene PDE5A and neoplasm.